Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PACS (PACS) EBITDA: 2023-2025

Historic EBITDA for PACS (PACS) over the last 3 years, with Q3 2025 value amounting to $86.3 million.

  • PACS's EBITDA rose 27567.06% to $86.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $237.7 million, marking a year-over-year increase of 16875.09%. This contributed to the annual value of $123.1 million for FY2024, which is 4076.54% down from last year.
  • As of Q3 2025, PACS's EBITDA stood at $86.3 million, which was up 27567.06% from $51.0 million recorded in Q2 2025.
  • In the past 5 years, PACS's EBITDA ranged from a high of $86.3 million in Q3 2025 and a low of -$32.1 million during Q2 2024
  • Moreover, its 3-year median value for EBITDA was $37.0 million (2023), whereas its average is $40.0 million.
  • In the last 5 years, PACS's EBITDA crashed by 3691.56% in 2024 and then skyrocketed by 27567.06% in 2025.
  • Quarter analysis of 3 years shows PACS's EBITDA stood at $62.5 million in 2023, then grew by 15.1% to $72.0 million in 2024, then rose by 19.85% to $86.3 million in 2025.
  • Its EBITDA was $86.3 million in Q3 2025, compared to $51.0 million in Q2 2025 and $28.5 million in Q1 2025.